1. Home
  2. AEVA vs EVO Comparison

AEVA vs EVO Comparison

Compare AEVA & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AEVA

Aeva Technologies Inc.

HOLD

Current Price

$24.84

Market Cap

1.3B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.00

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEVA
EVO
Founded
2019
1993
Country
United States
Germany
Employees
239
4553
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
934.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AEVA
EVO
Price
$24.84
$3.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$26.50
$7.00
AVG Volume (30 Days)
2.1M
85.0K
Earning Date
05-06-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$85.37
$1.37
Revenue Next Year
$132.72
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.83
$2.31
52 Week High
$38.79
$4.48

Technical Indicators

Market Signals
Indicator
AEVA
EVO
Relative Strength Index (RSI) 71.98 53.04
Support Level $12.37 $2.88
Resistance Level N/A $3.36
Average True Range (ATR) 2.45 0.09
MACD 0.60 -0.01
Stochastic Oscillator 94.44 54.34

Price Performance

Historical Comparison
AEVA
EVO

About AEVA Aeva Technologies Inc.

Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The 4D LiDAR sensors are designed to detect both velocity and position, supporting perception and decision-making in automated systems. The company operates in North America, EMEA, and Asia. The company's revenue consists of sales of perception solutions or sensing systems and non-recurring engineering services. Geographically, it derives the majority of its revenue from North America.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: